Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review
People with Down Syndrome (DS) are at high risk of developing Alzheimer's disease dementia (AD) and cerebral amyloid angiopathy, which is a critical factor contributing to dementia in sporadic AD. Predicting and monitoring the decline and onset of dementia is a diagnostic challenge and of essen...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024174762 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841533297316855808 |
|---|---|
| author | Charlotte Jacob Marleen Tollenaere Hanane Kachar Marie-Claude Potier Peter Paul De Deyn Debby Van Dam |
| author_facet | Charlotte Jacob Marleen Tollenaere Hanane Kachar Marie-Claude Potier Peter Paul De Deyn Debby Van Dam |
| author_sort | Charlotte Jacob |
| collection | DOAJ |
| description | People with Down Syndrome (DS) are at high risk of developing Alzheimer's disease dementia (AD) and cerebral amyloid angiopathy, which is a critical factor contributing to dementia in sporadic AD. Predicting and monitoring the decline and onset of dementia is a diagnostic challenge and of essence in daily care and support for people with DS. In this literature scoping review, we first summarize the different blood-based biomarkers for AD in DS. Next, we describe urine-based biomarkers for AD in DS and finally, we explore various blood-based biomarkers in the general AD population. Apart from the classic amyloid beta and Tau biomarkers, we also discuss more out-of-the-box biomarkers such as neurofilament light chain, Dual-specificity tyrosine-regulated kinase 1A, and monoaminergic biomarkers. These potential biomarkers could be a valuable addition to the established panel of fluid biomarkers. |
| format | Article |
| id | doaj-art-4348ec40194d4f818d6869a8fd1ff32a |
| institution | Kabale University |
| issn | 2405-8440 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj-art-4348ec40194d4f818d6869a8fd1ff32a2025-01-17T04:51:17ZengElsevierHeliyon2405-84402025-01-01111e41445Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature reviewCharlotte Jacob0Marleen Tollenaere1Hanane Kachar2Marie-Claude Potier3Peter Paul De Deyn4Debby Van Dam5Laboratory of Neurochemistry and Behaviour, Experimental Neurobiology Unit, University of Antwerp, BelgiumLaboratory of Neurochemistry and Behaviour, Experimental Neurobiology Unit, University of Antwerp, Belgium; Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, BelgiumLaboratory of Neurochemistry and Behaviour, Experimental Neurobiology Unit, University of Antwerp, BelgiumInstitut du Cerveau, Pitié-Salpêtrière Hospital, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Sorbonne Université, Paris, FranceLaboratory of Neurochemistry and Behaviour, Experimental Neurobiology Unit, University of Antwerp, Belgium; Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium; Department of Neurology and Alzheimer Center, University of Groningen and University Medical Center Groningen, Groningen, the NetherlandsLaboratory of Neurochemistry and Behaviour, Experimental Neurobiology Unit, University of Antwerp, Belgium; Department of Neurology and Alzheimer Center, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands; Corresponding author. Laboratory of Neurochemistry and Behaviour, Experimental Neurobiology Unit, University of Antwerp, Belgium.People with Down Syndrome (DS) are at high risk of developing Alzheimer's disease dementia (AD) and cerebral amyloid angiopathy, which is a critical factor contributing to dementia in sporadic AD. Predicting and monitoring the decline and onset of dementia is a diagnostic challenge and of essence in daily care and support for people with DS. In this literature scoping review, we first summarize the different blood-based biomarkers for AD in DS. Next, we describe urine-based biomarkers for AD in DS and finally, we explore various blood-based biomarkers in the general AD population. Apart from the classic amyloid beta and Tau biomarkers, we also discuss more out-of-the-box biomarkers such as neurofilament light chain, Dual-specificity tyrosine-regulated kinase 1A, and monoaminergic biomarkers. These potential biomarkers could be a valuable addition to the established panel of fluid biomarkers.http://www.sciencedirect.com/science/article/pii/S2405844024174762BloodUrineNeurofilament light chainMonoaminergic biomarkersDYRK1ACerebral amyloid angiopathy |
| spellingShingle | Charlotte Jacob Marleen Tollenaere Hanane Kachar Marie-Claude Potier Peter Paul De Deyn Debby Van Dam Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review Heliyon Blood Urine Neurofilament light chain Monoaminergic biomarkers DYRK1A Cerebral amyloid angiopathy |
| title | Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review |
| title_full | Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review |
| title_fullStr | Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review |
| title_full_unstemmed | Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review |
| title_short | Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review |
| title_sort | exploring peripheral fluid biomarkers for early detection of alzheimer s disease in down syndrome a literature review |
| topic | Blood Urine Neurofilament light chain Monoaminergic biomarkers DYRK1A Cerebral amyloid angiopathy |
| url | http://www.sciencedirect.com/science/article/pii/S2405844024174762 |
| work_keys_str_mv | AT charlottejacob exploringperipheralfluidbiomarkersforearlydetectionofalzheimersdiseaseindownsyndromealiteraturereview AT marleentollenaere exploringperipheralfluidbiomarkersforearlydetectionofalzheimersdiseaseindownsyndromealiteraturereview AT hananekachar exploringperipheralfluidbiomarkersforearlydetectionofalzheimersdiseaseindownsyndromealiteraturereview AT marieclaudepotier exploringperipheralfluidbiomarkersforearlydetectionofalzheimersdiseaseindownsyndromealiteraturereview AT peterpauldedeyn exploringperipheralfluidbiomarkersforearlydetectionofalzheimersdiseaseindownsyndromealiteraturereview AT debbyvandam exploringperipheralfluidbiomarkersforearlydetectionofalzheimersdiseaseindownsyndromealiteraturereview |